Report: Sentinels Valorant To Replace zombs With Kanpeki 

Akrew player Kanpeki may soon sport a Sentinels jersey.

As per reports from George Geddes of dotesports, North American organisation Sentinels are in talks with Eric ‘Kanpeki’ Xu, to sign him to their Valorant roster. The move will see zombs on the bench to make way for Kanpeki, who has been practicing with Sentinels of late.

Valorant Champions Tour Stage 2 Challengers is set to kick off next week, on April 28th and the roster lock for it, ends April 21st at 11:59PM EST. So a deal needs to be struck soon, if Kanpeki is to represent Sentinels at VCT Stage 2 Challengers.

As stated earlier Jared “zombs” Gitlin will be moved to the bench, but as per the report, should the move not come to fruition, zombs will continue on Sentinels’ Valorant roster.

Controversy ridden Valorant player Jay ‘Sinatraa’ Won will not be making his return to the roster for the time being, even though he had been cleared by Riot at first, to compete again, as per his twitlonger.

But since he had not completed his training, the community didn’t hold back and both Riot and Sinatraa faced immense backlash. Following this, Riot Games’ President, esports – John Needham published a statement.

“We have informed Mr Won that contrary to that communication, and in accordance with the competitive ruling, he is required to undergo professional conduct training.”

Sinatraa hasn’t been found guilty in any of the accusations made by his former girlfriend Cleo Hernandez, of sexual misconduct, parts of which were confirmed by the audios she posted but were conveniently not mentioned at all by Sinatraa in his statement regarding his return.

As for Sentinels, they will need to confirm the signing of Akrew talent Kanpeki by tonight, if he is to represent them at VCT Stage 2 Challengers 2022 NA.

Kanpeki has been with Akrew since October 2021, and won a handful of  C-tier tournaments with them, most notably NSG Winter Championship – Philadelphia, which was held on LAN in January 2022.

More updates are awaited.